The Movie Theater Study: Understanding Meal Effects

This study, called "The Movie Theater Study," is looking at how a typical movie theater meal (popcorn, soda, and candy) affects your body. Researchers want to understand how these foods impact your blood sugar (hyperglycemia), insulin levels (hyperinsulinemia), and fats in your blood (triglycerides). You could be eligible if you are between 18 and 45 years old, not pregnant or postmenopausal, and haven't been diagnosed with heart disease, type 2 diabetes, or chronic inflammatory conditions. The study aims to describe these effects, but its current status is unclear and it plans to enroll 10 participants.

Study design
This interventional study involves 10 participants completing two different meal scenarios in random order.
What's involved
You will have two study visits, each involving fasting, blood draws, and consuming specific meals (either a movie theater meal or a high-fat meal followed by a movie theater meal).
Compensation
Not stated in the trial record.
Follow-up
Your glucose, insulin, and triglyceride levels will be measured through study completion, up to 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06444984

The Movie Theater Study

UNKNOWN
NAAges 18–45Interventional
Ball State University
~10 participants
Updated 2024-06-06 on ClinicalTrials.gov
What's tested:Fasting TrialFed Trial

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Glucose
Measured over Through study completion, up to 1 year.
+7 more outcomes measured
Hyperglycemia, Postprandial
Hyperinsulinemia

NCT06444984

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Health Professions Building, Ball State University

    Muncie, Indianastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Bryant Keirns · PRINCIPAL_INVESTIGATOR · Ball State University

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18-45 years old
Not pregnant or expecting to become pregnant (females only)
Not postmenopausal (females only).
Not been diagnosed with a cardiometabolic conditions (e.g., heart disease, type 2 diabetes)
Not been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
Does not regularly take anti-inflammatory drugs (more than 2x week) or able to temporarily suspend use of anti-inflammatory drugs.
Does not use glucose-lowering drugs (e.g., metformin)
Does not use lipid-lowering drugs (e.g., statins)
Does not use tobacco products or any illicit drugs.
Does not have a pacemaker.

Exclusion

Not 18-45 years old
Pregnant or expecting to become pregnant (females only)
Postmenopausal (females only).
Been diagnosed with a cardiometabolic conditions (e.g., heart disease, type 2 diabetes)
Been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
Regularly take anti-inflammatory drugs (more than 2x week) or unable to temporarily suspend use of anti-inflammatory drugs.
Use glucose-lowering drugs (e.g., metformin)
Use lipid-lowering drugs (e.g., statins)
Use tobacco products or any illicit drugs.
Has a pacemaker.
  • GlucoseThrough study completion, up to 1 year.

    The investigators will measure glucose at baseline and 0.5-, 1-, 2-, 3-, and 4-hours after each meal trial.

  • InsulinThrough study completion, up to 1 year.

    The investigators will measure serum insulin at baseline and 0.5-, 1-, 2-, 3-, and 4-hours after each meal trial.

  • TriglyceridesThrough study completion, up to 1 year.

    The investigators will measure triglycerides at baseline and 0.5-, 1-, 2-, 3-, and 4-hours after each meal trial.

  • HDL-CThrough study completion, up to 1 year.

    The investigators will measure HDL-C at baseline and 0.5-, 1-, 2-, 3-, and 4-hours after each meal trial.

  • Lipopolysaccharide binding protein (LBP)Through study completion, up to 1 year.

    The investigators will measure serum LBP at baseline and 0.5-, 1-, 2-, 3-, and 4-hours. after each meal trial.

  • soluble CD14 (sCD14)Through study completion, up to 1 year.

    The investigators will measure serum sCD14 at baseline and 0.5-, 1-, 2-, 3-, and 4-hours after each meal trial.

  • Interleukin (IL)-6Through study completion, up to 1 year.

    The investigators will measure serum IL-6 at baseline and 0.5-, 1-, 2-, 3-, and 4-hours after each meal trial.

  • Flow-mediated dilationThrough study completion, up to 1 year.

    The investigators will measure FMD at baseline, 2-hours, and 4-hours after each meal trial.